Strategic Acquisition Potential cross-sell opportunities leveraging the demonstrated inorganic growth, evidenced by the 2021 acquisition of Panacea Life Sciences, to introduce bundled hemp-derived CBD products and pet-friendly formulations to new and existing channels.

Channel Expansion Green Goddess branded products and third-party resellers indicate a multi-channel distribution approach; partner with暴 retailers, e-commerce platforms, and white-label manufacturers to scale supply of cGMP hemp extracts and finished goods.

Compliance Focus Emphasize solutions around regulatory compliance, traceability, and quality control for hemp-derived ingredients given the focus on low-THC products and plans for direct extraction in cGMP facilities.

Operational Scale Target mid-market and niche wellness brands seeking reliable hemp ingredients; offer farm-to-factory supply, contract manufacturing, and ingredient supply agreements to support growth in CBD and feminized hemp genetics.

Executive Network Leverage the shown leadership appointments and board activity to engage C-suite stakeholders with value propositions around strategic partnerships, capital-efficient product development, and long-term farming partnerships.